Answers are grounded in this paper and cite their sources.
Macular edema is a common cause of vision loss in patients with diabetes. Chronic elevation of serum glucose levels leads to capillary damage that results in microaneurysm formation in the retina. Leakage from these microaneurysms leads to vision loss if the fluid involves the center of the fovea. The mainstay of therapy for more than 25 years was focal laser photocoagulation applied to or near the microaneurysms.1 However, results from clinical trials of drugs that block vascular endothelial growth factor (VEGF) for the treatment of diabetic macular edema have led to a dramatic shift away from laser therapy to primary . . .
No takes yet. Share an insight, caveat, or question.
Martín et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: